Nanostructured sensors for biomedical applications-a current perspective

Current Opinion in Biotechnology

Volumn 34, Issue , 2015, Pages 118-124

  Krishnamoorthy, Sivashankar ^a  

^a LUXEMBOURG INSTITUTE OF SCIENCE AND TECHNOLOGY   (Luxembourg)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG THERAPY; MEDICAL APPLICATIONS; NANOSTRUCTURES;

BIOMEDICAL APPLICATIONS; EARLY-STAGE DIAGNOSIS; HEALTH CONDITION; HIGH THROUGHPUT; IN-VITRO DIAGNOSTIC; MOBILE HEALTH CARE; NANOSTRUCTURED SENSORS; PREDICTIVE MODELS;

DIAGNOSIS;

NANOMATERIAL;

BIOLOGICAL MONITORING; BIOMEDICINE; BIOSENSOR; DIAGNOSTIC EQUIPMENT; DIAGNOSTIC TEST; DISEASE MARKER; HEALTH CARE NEED; HIGH THROUGHPUT SCREENING; IN VITRO STUDY; MEDICAL TECHNOLOGY; MOLECULAR DIAGNOSTICS; MOLECULAR GENETICS; NANOTECHNOLOGY; PERSONALIZED MEDICINE; PREDICTION; REGENERATIVE MEDICINE; REVIEW; SOCIAL MARKETING; TELEHEALTH; CHEMISTRY; GENETIC PROCEDURES; HUMAN; MEDICAL RESEARCH;

BIOMEDICAL RESEARCH; BIOSENSING TECHNIQUES; HUMANS; NANOSTRUCTURES;

EID: 84923010625     PISSN: 09581669     EISSN: 18790429     Source Type: Journal    
DOI: 10.1016/j.copbio.2014.11.019     Document Type: Review

References (51)

1. The Case for Personalized Medicine. 4th Edition Personalized Medicine Coalition; 2014. The report provides a current perspective on personalized medicine, with concrete examples presented with clinical, technological, and policy related viewpoints (freely downloadable at: ). http://www.personalizedmedicinecoalition.org/Userfiles/PMC-Corporate/file/pmc_the_case_for_personalized_medicine.pdf.
2. Personalized Medicine: Trends and Prospects for the new Science of Genetic Testing and Molecular Diagnostics, Working paper 7. United Health Center for Health Reform & Modernization; 2012.
3. Rusling J.F., Kumar C.V., Gutkind J.S., Patel V. Measurement of biomarker proteins for point-of-care early detection and monitoring of cancer. Analyst 2010, 135:2496-2511.
4. Hakim M., Broza Y.Y., Barash O., Peled N., Phillips M., Amann A., Haick H. Volatile organic compounds of lung cancer and possible biochemical pathways. Chem Rev 2012, 112:5949-5966.
5. Speicher M.R., Pantel K. Tumor signatures in the blood. Nat Biotechnol 2014, 32:441-443.
6. Bu L., Shen B., Cheng Z. Fluorescent imaging of cancerous tissues for targeted surgery. Adv Drug Deliv Rev 2014, 76:21-38.
7. Lee S.Y., Jeon S.I., Jung S., Chung I.J., Ahn C.H. Targeted multimodal imaging modalities. Adv Drug Deliv Rev 2014, 76:60-78.
8. Toy R., Bauer L., Hoimes C., Ghaghada K.B., Karathanasis E. Targeted nanotechnology for cancer imaging. Adv Drug Deliv Rev 2014, 76:79-97.
9. Keunen O., Taxt T., Gruner R., Lund-Johansen M., Tonn J.C., Pavlin T., Bjerkvig R., Niclou S.P., Thorsen F. Multimodal imaging of gliomas in the context of evolving cellular and molecular therapies. Adv Drug Deliv Rev 2014, 76:98-115.
10. Diagnostics 2011 M&A Surges, Companion Diagnostics Accelerate, and Early Detection Offers New Prospects 2011, PWC.
11. Strategic Review of Molecular Diagnostics Changing Traditional Health Care Paradigm 2010, Scientia Advisors.
12. Global DNA Diagnostics Market 2014, Allied Market Research.
13. Haruya M., Kano S. A new look at the corporate capability of personalized medicine development in the pharmaceutical industry. R&D Manag 2014, 10.1111/radm.12072.
14. Gubala V., Harris L.F., Ricco A.J., Tan M.X., Williams D.E. Point of care diagnostics: status and future. Anal Chem 2011, 84:487-515.
15. Huckle D. Point-of-care diagnostics: an advancing sector with nontechnical issues. Expert Rev Mol Diagn 2008, 8:679-688.
16. Rajan A., Glorikian H. Point-of-care diagnostics: market trends and growth drivers. Expert Opin Med Diagn 2008, 3:1-4.
17. Vashist S.K., Schneider E.M., Luong J.H. Commercial smartphone-based devices and smart applications for personalized healthcare monitoring and management. Diagnostics 2014, 4:104-128.
18. Telehealth and Telemedicine - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2018 2012, GDME0162MAR, Global Data.
19. mHealth Elderly Home Monitoring Growth Drawing New Players to the Market 2014, ABI Research.
20. Macarron R., Banks M.N., Bojanic D., Burns D.J., Cirovic D.A., Garyantes T., Green D.V., Hertzberg R.P., Janzen W.P., Paslay J.W. Impact of high-throughput screening in biomedical research. Nat Rev Drug Discov 2011, 10:188-195.
21. Oliveira M.B., Mano J.F. High-throughput screening for integrative biomaterials design: exploring advances and new trends. Trends Biotechnol 2014, 32:627-636.
22. Dahoumane S., Helka B.J., Artus M., Aubie B., Brennan J. High-throughput screening for the production of biomaterials: a new tool for the study of the interactions between materials and biological species. Handbook of Nanomaterials Properties 2014, 995-1021. Springer, Berlin Heidelberg. B. Bhushan, D. Luo, S.R. Schricker, W. Sigmund, S. Zauscher (Eds.).
23. Taylor D.L., Giuliano K.A. High Content Screening, Encyclopedia of Genetics, Genomics, Proteomics and Bioinformatics 2004, John Wiley & Sons, Ltd.
24. Cell Analysis The Whole Story-Instruments, Equipment, Cell Culture and More 2014, Strategic Directions International, Inc.
25. Li M., Cushing S.K., Wu N. Plasmon-enhanced optical sensors: a review. Analyst 2014, 10.1039/C4AN01079E.
26. Tokel O., Inci F., Demirci U. Advances in plasmonic technologies for point of care applications. Chem Rev 2014, 114:5728-5752.
27. Im H., Shao H., Park Y.I., Peterson V.M., Castro C.M., Weissleder R., Lee H. Label-free detection and molecular profiling of exosomes with a nano-plasmonic sensor. Nat Biotechnol 2014, 32:490-495.
28. Inci F., Tokel O., Wang S., Gurkan U.A., Tasoglu S., Kuritzkes D.R., Demirci U. Nanoplasmonic quantitative detection of intact viruses from unprocessed whole blood. ACS Nano 2013, 7:4733-4745.
29. Preechaburana P., Gonzalez M.C., Suska A., Filippini D. Surface plasmon resonance chemical sensing on cell phones. Angew Chem 2012, 124:11753-11756.
30. Tabakman S.M., Lau L., Robinson J.T., Price J., Sherlock S.P., Wang H., Zhang B., Chen Z., Tangsombatvisit S., Jarrell J.A. Plasmonic substrates for multiplexed protein microarrays with femtomolar sensitivity and broad dynamic range. Nat Commun 2011, 2:466.
31. Zhang B., Kumar R.B., Dai H., Feldman B.J. A plasmonic chip for biomarker discovery and diagnosis of type 1 diabetes. Nat Med 2014, 20:948-953.
32. Zavaleta C.L., Garai E., Liu J.T., Sensarn S., Mandella M.J., Van de Sompel D., Friedland S., Van Dam J., Contag C.H., Gambhir S.S. A Raman-based endoscopic strategy for multiplexed molecular imaging. Proc Natl Acad Sci 2013, 110:E2288-E2297.
33. Wu Z., Liu Y., Zhou X., Shen A., Hu J. A turn-offSERS-based detection platform for ultrasensitive detection of thrombin based on enzymatic assays. Biosens Bioelectron 2013, 44:10-15.
34. Chen G., Chen Y., Zheng X., He C., Lu J., Feng S., Chen R., Zeng H. Surface-enhanced Raman scattering study of carcinoembryonic antigen in serum from patients with colorectal cancers. Appl Phys B 2013, 113:597-602.
35. Li M., Cushing S.K., Zhang J., Suri S., Evans R., Petros W.P., Gibson L.F., Ma D., Liu Y., Wu N. Three-dimensional hierarchical plasmonic nano-architecture enhanced surface-enhanced Raman scattering immunosensor for cancer biomarker detection in blood plasma. ACS Nano 2013, 7:4967-4976.
36. Lee S., Chon H., Lee J., Ko J., Chung B.H., Lim D.W., Choo J. Rapid and sensitive phenotypic marker detection on breast cancer cells using surface-enhanced Raman scattering (SERS) imaging. Biosens Bioelectron 2014, 51:238-243.
37. Yamamoto Y.S., Ishikawa M., Ozaki Y., Itoh T. Fundamental studies on enhancement and blinking mechanism of surface-enhanced Raman scattering (SERS) and basic applications of SERS biological sensing. Front Phys 2014, 9:31-46.
38. Baaske M.D., Foreman M.R., Vollmer F. Single-molecule nucleic acid interactions monitored on a label-free microcavity biosensor platform. Nat Nanotechnol 2014, 9:933-939.
39. Wu X., Oo M.K.K., Reddy K., Chen Q., Sun Y., Fan X. Optofluidic laser for dual-mode sensitive biomolecular detection with a large dynamic range. Nat Commun 2014, 5.
40. Labroo P., Cui Y. Flexible graphene bio-nanosensor for lactate. Biosens Bioelectron 2013, 41:852-856.
41. Windmiller J.R., Wang J. Wearable electrochemical sensors and biosensors: a review. Electroanalysis 2013, 25:29-46.
42. Gou P., Kraut N.D., Feigel I.M., Bai H., Morgan G.J., Chen Y., Tang Y., Bocan K., Stachel J., Berger L. Carbon nanotube chemiresistor for wireless pH sensing. Scientific Rep 2014, 4. 10.1038/srep04468.
43. Wang X., Gu Y., Xiong Z., Cui Z., Zhang T. Silk-molded flexible, ultrasensitive, and highly stable electronic skin for monitoring human physiological signals. Adv Mater 2014, 26:1336-1342.
44. Webb R.C., Bonifas A.P., Behnaz A., Zhang Y., Yu K.J., Cheng H., Shi M., Bian Z., Liu Z., Kim Y.S., et al. Ultrathin conformal devices for precise and continuous thermal characterization of human skin. Nat Mater 2013, 12:938-944.
45. Son D., Lee J., Qiao S., Ghaffari R., Kim J., Lee J.E., Song C., Kim S.J., Lee D.J., Jun S.W. Multifunctional wearable devices for diagnosis and therapy of movement disorders. Nat Nanotechnol 2014, 9:397-404.
46. Shyamkumar P., Rai P., Oh S., Ramasamy M., Harbaugh R.E., Varadan V. Wearable wireless cardiovascular monitoring using textile-based nanosensor and nanomaterial systems. Electronics 2014, 3:504-520.
47. Dimmeler S., Ding S., Rando T.A., Trounson A. Translational strategies and challenges in regenerative medicine. Nat Med 2014, 20:814-821.
48. Jiang N., Zhang S., Ma K. An ID card for T cells. Nat Biotechnol 2014, 32:639-640.
49. El-Ali J., Sorger P.K., Jensen K.F. Cells on chips. Nature 2006, 442:403-411.
50. Helmke B.P., Minerick A.R. Designing a nano-interface in a microfluidic chip to probe living cells: challenges and perspectives. Proc Natl Acad Sci 2006, 103:6419-6424.
51. Ma C., Fan R., Ahmad H., Shi Q., Comin-Anduix B., Chodon T., Koya R.C., Liu C.C., Kwong G.A., Radu C.G. A clinical microchip for evaluation of single immune cells reveals high functional heterogeneity in phenotypically similar T cells. Nat Med 2011, 17:738-743.